Three Territory Sign in COVID-19
Acta Neurol Belg doi.10.1007/s13760-021-01842-8, Bhatele, P.,et al, 2022
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
NEJM 382:e38, Zhang, Y.,et al, 2020
Scoping Review of Prevalence of Neurologic Comorbidities in Patients Hospitalized for COVID-19
Neurol 95:77-84, Herman, C.,et al, 2020
Acute Encephalitis in Immunocompetent Adults
Lancet 393:702-716, Venkatesan, A.,et al, 2019
Varicella-Zoster Virus Infections in Patients Treated with Fingolimod
JAMA Neurol 72:31-39,10, Arvin, A.M.,et al, 2015
HIV Status and the Risk of Ischemic Stroke Among Men
Neurol 84:1933-1940, Sico, J.J.,et al, 2015
Neurologic Complications in Dengue Virus Infection
Neurol 83:1601-1609,1590, Sahu, R.,et al, 2014
Differential Features of Carotid and Vertebral Artery Dissections
Neurol 77:1174-1181, Debette, S.,et al, 2011
HIV Disease in the Caribbean
Top Antivir Med 19:e1-e5, Pape, J.W.,et al, 2011
Infectious Burden and Risk of Stroke: The Northern Manhattan Study
Arch Neurol 67:33-38, 16, Elkind,M.,et al, 2010
Herpes Zoster Ophthalmicus and the Risk of Stroke: A Population-Based Follow-up Study
Neurol 74:792-797, 788, Lin, H.-C.,et al, 2010
AIDS-Related Lymphomas: Epidemiology, Risk Factors, and Pathobiology
UpToDate, Sept, Kaplan, L.D.,et al, 2010
Triple and Quadruple Spontaneous Cervical Artery Dissection: Presenting Characteristics and Long-Term Outcome
JNNP 80:171-174,130, Arnold,M.,et al, 2009
Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009
Increased Risk of Stroke After a Herpes Zoster Attack
Stroke 40:3443-3448, Kang,J.,et al, 2009
Multiple Sclerosis After Infectious Mononucleosis
Arch Neurol 64:72-75, Nielsen,T.R.,et al, 2007
Neurotropic Viruses and Cerebral Palsy: Population Based Case-Control Study
BMJ 332:76-79,63, Gibson,C.S.,et al, 2006
Stroke in Childhood
The Neurologist 12:94-102, Jordan,L.C., 2006
Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis
JAMA 293:2496-2500, Levin,L.I.,et al, 2005
Epstein-Barr Virus in Pediatric Multiple Sclerosis
JAMA 291:1875-1879, Alotaibi,S.,et al, 2004
Infection and Risk of Ischemic Stroke
Stroke 34:452-457, Paganini-Hill,A.,et al, 2003
Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke Among the Elderly
NEJM 348:1322-1332, Nichol,K.L.,et al, 2003
Association Between Influenza Vaccination and Reduced Risk of Brain Infarction
Stroke 33:513-518, LavalTe,P.,et al, 2002
West Nile Virus: A Primer for the Clinician
Ann Int Med 137:173-179, Petersen,L.R. &Marfin,A.A., 2002
Chickenpox and Stroke in Childhood
Stroke 32:1257-1262, Askalan,R.,et al, 2001
Epidemic West Nile Encephalitis, New York, 1999: Results of a Household-based Seroepidemiological Survey
Lancet 358:261-264,254, Mostashari,F.,et al, 2001
Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis
JAMA 286:3083-3088,3127, Ascherio,A.,et al, 2001
Multiple Sclerosis and Antecedent Infections
Neurol 54:2307-2310, Marrie,R.A.,et al, 2000
Varicella as a Risk Factor for Cerebral Infarction in Childhood:A Case-Control Study
Ann Neurol 45:679-680, Sebire,G.,et al, 1999
Association of Cervical Artery Dissection with Recent Infection
Arch Neurol 56:851-856, Grau,A.J.,et al, 1999
Recent Bacterial & Viral Infect is a Risk Factor for Cerebrovascular Ischemia, Clinical & Biochem Studies
Neurol 50:196-203, Grau,A.J.,et al, 1998
Antepartum Risk Factors for Newborn Encephalopathy:The Western Australian Case-Control Study
BMJ 317:1549-1553,1537, Badawi,N.,et al, 1998
HTLV-Associated Myelopathy in a Cohort of HTLV-I and HTLV-II Infected Blood Donors
neurol 48:315-320, Murphy,E.L.,et al, 1997
Myasthenic Crisis:Clinical Features, Mortality, Comp, & Risk Factors for Prolonged Intubation
Neurol 48:1253-1254, Thomas,C.E.,et al, 1997
Recent Infection as a Risk Factor for Cerebrovascular Ischemia
Stroke 26:373-379, Grau,A.J.,et al, 1995
Subcortical Infarction in Children
Stroke 25:117-121, Powell,F.C.,et al, 1994
Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity
Ann Neurol 94:146-159, Giraldo,G.S.P.,et al, 2023
Progressive Multifocal Leukoencephalopathy in a Patient with Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy
JAMA Neurol 78:736-740, Patel,A.,et al, 2021
Infection Risks Among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
JAMA Neurol 77:184-191, Luna, G.,et al, 2020
Neurologic Complications of Coronavirus Infections
Neurol 94:809-810, Nath, A., 2020
Clinicopathologic Conference, Cerebrovascular Accident Probably Related to SARS-CoV2 Infection
NEJM 383:764-773, Case 26-2020, 2020
Neuroimaging Findings of Zika Virus-Associated Neurologic Complications in Adults
AJNR 39:1967-1974, Hygino da Cruz, L.C.,et al, 2018
Diagnostic Challenges and Clinical Characteristics of Hepatitis E Virus-Associated Guillain-Barre Syndrome
JAMA Neurol 74:26-33, Stevens, O.,et al, 2017
Viral Hepatitis and Parkinson Disease
Neurol 88:1630-1633, Pakpoor, J.,et al, 2017
Bone Marrow Necrosis and Fat Embolism Syndrome in Sickle Cell Disease: Increased Susceptibility of Patients with Non-SS genotypes and a Possible Association with Human Parvovirus B19 Infection
Blood Rev 28:23-30, Tsitsikas, D.A.,et al, 2014
Varicella-Zoster Virus Acute Myelitis in a Patient with MS Treated with Natalizumab
Neurol 80:1812-1813, Yeung, J.,et al, 2013
Eastern Equine Encephalitis Virus - Old Enemy, New Threat
NEJM 368:1670-1673, Armstrong, P. & Andreadis, T., 2013
Central Nervous System Involvement in Dengue
Neurol 78:736-742, Araujo,F.M.C.,et al, 2012
Guillain-Barre Syndrome
NEJM 366:2294-2304, Yuki, N. & Hartung, H.P., 2012